Pycnogenol
•Last Updated: September 28 2022
Pine Bark Extract; Pycnogenol is investigated for its general health and anti-diabetic properties and its ability to enhance Nitric Oxide, which may have a significant benefit for those with erectile dysfunction. Recent studies have also shown that supplementation may help to limit symptoms associated with chronic inflammation in autoimmune disease.
Pycnogenol is most often used for
Last Updated: September 28 2022
Pycnogenol is a patented formulation of Pine Bark Extract which is standardized to 65-75% Procyanidin compounds by weight. Procyanidins are chain-like structures consisted of catechins similar to some found in green tea (the green tea catechins that do not have 'gallate' in their names). Pycnogenol is similar to grape seed extract and cocoa polyphenols as those are the three most common sources of Procyanidins.
Pycnogenol's benefits include increased blood flow (via a mechanism related to increased nitric oxide levels) and improved blood glucose control. The former exerts cardioprotective effects and may help with erectile dysfunction, while the latter appears to be anti-diabetic.
There are many human trials conducted on Pycnogenol, but a good deal of them have industry funding. Although industry funding doesn't necessarily invalidate published results, it should always be noted. Although the range of Pycnogenol research has significant breadth, it also has a relative lack of study replication. Some of the studies of Pycnogenol in autoimmune disease are also open-label, meaning that neither the researchers nor the subjects are blinded to treatments. While promising, these results need to be interpreted with a degree of caution since this type of experimental design fails to control for placebo effects or any unconscious bias that may be harbored by researchers analyzing the data. The one topic that appears to have been replicated numerous times is the effects on erectile dysfunction, with the caveat that all of the studies are confounded with the inclusion of l-arginine. So the effects of Pycnogenol alone on erectile dysfunction are still unknown.
Pycnogenol does appear to possess dual anti-oxidant and anti-inflammatory properties, with the latter being confirmed in humans and possibly being subject to a build-up effect over time. The low-dose buildup effect of Pycnogenol as an anti-inflammatory agent would make it useful in a multinutrient format, but it may not be the most potent anti-inflammatory in isolation. The degree of measured anti-inflammatory potential on COX enzymes (targets of Aspirin) are still lower than Aspirin itself.
Although not the most potent anti-inflammatory agent out there, Pycnogenol has shown some efficacy in alleviating symptoms in patients with autoimmune disease. Although the type of rampant inflammation during a flare far-exceeds the ability of pycnogenol, it has shown some efficacy for patients in remission phases of their disease, where symptoms tend to be driven by lower-level, chronic inflammation. One preliminary study has shown that pycnogenol may be particularly effective for relieving dry eye/dry mouth symptoms associated with Sjogren’s syndrome, a common autoimmune condition in women.
Note that Pycnogenol is also known as:
- Pine Bark Extract
- Pine Bark Procyanidins
- Procyanidins
Pycnogenol should not be confused with:
- Grape Seed Extract (same molecules but different source)
Although doses in the range of 40-60mg have been noted to be effective over a prolonged period of time, standard doses of Pycnogenol appear to be in the range of 100-200 mg per day.
Studies have used twice daily dosing (dividing the daily total into two even doses to be taken with breakfast and dinner) as well as once daily dosing with breakfast. Both dosing strategies appear to be effective although they haven't been directly compared. It can be asborbed equally well when taken with or without food.
What works and what doesn't?
Unlock the full potential of Examine
Latest ResearchRead all studies
1.^Chen P, Song F, Lin LZChromatographic fingerprint analysis of Pycnogenol dietary supplementsJ AOAC Int.(2009 Mar-Apr)
2.^Kurlbaum M, Högger PPlasma protein binding of polyphenols from maritime pine bark extract (USP)J Pharm Biomed Anal.(2011 Jan 5)
3.^Grimm T, Skrabala R, Chovanová Z, Muchová J, Sumegová K, Liptáková A, Duracková Z, Högger PSingle and multiple dose pharmacokinetics of maritime pine bark extract (pycnogenol) after oral administration to healthy volunteersBMC Clin Pharmacol.(2006 Aug 3)
4.^Uhlenhut K, Högger PFacilitated cellular uptake and suppression of inducible nitric oxide synthase by a metabolite of maritime pine bark extract (Pycnogenol)Free Radic Biol Med.(2012 Jul 15)
5.^Düweler KG, Rohdewald PUrinary metabolites of French maritime pine bark extract in humansPharmazie.(2000 May)
6.^Roowi S, Stalmach A, Mullen W, Lean ME, Edwards CA, Crozier AGreen tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by humansJ Agric Food Chem.(2010 Jan 27)
7.^Stoupi S, Williamson G, Drynan JW, Barron D, Clifford MNA comparison of the in vitro biotransformation of (-)-epicatechin and procyanidin B2 by human faecal microbiotaMol Nutr Food Res.(2010 Jun)
8.^Das NPStudies on flavonoid metabolism. Absorption and metabolism of (+)-catechin in manBiochem Pharmacol.(1971 Dec)
9.^Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites.()
10.^Crozier A, Del Rio D, Clifford MNBioavailability of dietary flavonoids and phenolic compoundsMol Aspects Med.(2010 Dec)
11.^Grimm T, Schäfer A, Högger PAntioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (pycnogenol)Free Radic Biol Med.(2004 Mar 15)
12.^Carr A, Frei BThe role of natural antioxidants in preserving the biological activity of endothelium-derived nitric oxideFree Radic Biol Med.(2000 Jun 15)
13.^Fitzpatrick DF, Bing B, Rohdewald PEndothelium-dependent vascular effects of PycnogenolJ Cardiovasc Pharmacol.(1998 Oct)
14.^Nishioka K, Hidaka T, Nakamura S, Umemura T, Jitsuiki D, Soga J, Goto C, Chayama K, Yoshizumi M, Higashi YPycnogenol, French maritime pine bark extract, augments endothelium-dependent vasodilation in humansHypertens Res.(2007 Sep)
15.^Liu X, Wei J, Tan F, Zhou S, Würthwein G, Rohdewald PPycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patientsLife Sci.(2004 Jan 2)
16.^Lambert JD, Rice JE, Hong J, Hou Z, Yang CSSynthesis and biological activity of the tea catechin metabolites, M4 and M6 and their methoxy-derivativesBioorg Med Chem Lett.(2005 Feb 15)
17.^Terra X, Valls J, Vitrac X, Mérrillon JM, Arola L, Ardèvol A, Bladé C, Fernandez-Larrea J, Pujadas G, Salvadó J, Blay MGrape-seed procyanidins act as antiinflammatory agents in endotoxin-stimulated RAW 264.7 macrophages by inhibiting NFkB signaling pathwayJ Agric Food Chem.(2007 May 30)
18.^Kim HK, Cheon BS, Kim YH, Kim SY, Kim HPEffects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationshipsBiochem Pharmacol.(1999 Sep 1)
19.^Wang J, Mazza GInhibitory effects of anthocyanins and other phenolic compounds on nitric oxide production in LPS/IFN-gamma-activated RAW 264.7 macrophagesJ Agric Food Chem.(2002 Feb 13)
20.^Parveen K, Ishrat T, Malik S, Kausar MA, Siddiqui WAModulatory effects of Pycnogenol® in a rat model of insulin-dependent diabetes mellitus: biochemical, histological, and immunohistochemical evidencesProtoplasma.(2012 Jun 3)
21.^Peng YJ, Lee CH, Wang CC, Salter DM, Lee HSPycnogenol attenuates the inflammatory and nitrosative stress on joint inflammation induced by urate crystalsFree Radic Biol Med.(2012 Feb 15)
22.^Grimm T, Skrabala R, Chovanová Z, Muchová J, Sumegová K, Liptáková A, Duracková Z, Högger PSingle and multiple dose pharmacokinetics of maritime pine bark extract (pycnogenol) after oral administration to healthy volunteersBMC Clin Pharmacol.(2006 Aug 3)
23.^Virgili F, Pagana G, Bourne L, Rimbach G, Natella F, Rice-Evans C, Packer LFerulic acid excretion as a marker of consumption of a French maritime pine (Pinus maritima) bark extractFree Radic Biol Med.(2000 Apr 15)
24.^Schoefer L, Mohan R, Schwiertz A, Braune A, Blaut MAnaerobic degradation of flavonoids by Clostridium orbiscindensAppl Environ Microbiol.(2003 Oct)
25.^Jankyova S, Kmecova J, Cernecka H, Mesarosova L, Musil P, Brnoliakova Z, Kyselovic J, Babal P, Klimas JGlucose and blood pressure lowering effects of Pycnogenol® are inefficient to prevent prolongation of QT interval in experimental diabetic cardiomyopathyPathol Res Pract.(2012 Aug 15)
26.^Enseleit F, Sudano I, Périat D, Winnik S, Wolfrum M, Flammer AJ, Fröhlich GM, Kaiser P, Hirt A, Haile SR, Krasniqi N, Matter CM, Uhlenhut K, Högger P, Neidhart M, Lüscher TF, Ruschitzka F, Noll GEffects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over studyEur Heart J.(2012 Jul)
27.^Youn YJ, Lee JChronic venous insufficiency and varicose veins of the lower extremitiesKorean J Intern Med.(2019 Mar)
28.^Cesarone MR, Belcaro G, Rohdewald P, Pellegrini L, Ledda A, Vinciguerra G, Ricci A, Gizzi G, Ippolito E, Fano F, Dugall M, Acerbi G, Cacchio M, Di Renzo A, Hosoi M, Stuard S, Corsi MComparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled studyClin Appl Thromb Hemost.(2006 Apr)
30.^Petrassi C, Mastromarino A, Spartera CPYCNOGENOL in chronic venous insufficiencyPhytomedicine.(2000 Oct)
31.^Rainer KochComparative study of Venostasin and Pycnogenol in chronic venous insufficiencyPhytother Res.(2002 Mar)
32.^Belcaro G, Cesarone MR, Errichi BM, Ledda A, Di Renzo A, Stuard S, Dugall M, Pellegrini L, Rohdewald P, Ippolito E, Ricci A, Cacchio M, Ruffini I, Fano F, Hosoi MVenous ulcers: microcirculatory improvement and faster healing with local use of PycnogenolAngiology.(2005 Nov-Dec)
33.^Nuzum DS, Gebru TT, Kouzi SAPycnogenol for chronic venous insufficiencyAm J Health Syst Pharm.(2011 Sep 1)
34.^Grossi MG, Belcaro G, Cesarone MR, Dugall M, Hosoi M, Cacchio M, Ippolito E, Bavera PImprovement in cochlear flow with Pycnogenol® in patients with tinnitus: a pilot evaluationPanminerva Med.(2010 Jun)
35.^Luzzi R, Belcaro G, Hu S, Dugall M, Hosoi M, Cacchio M, Ippolito E, Corsi MImprovement in symptoms and cochlear flow with pycnogenol in patients with Meniere's disease and tinnitusMinerva Med.(2014 Jun)
36.^Hosseini S, Lee J, Ramon T, Sepulveda RT, Rohdewald P, Watson RRA randomized, double-blind, placebo-controlled, prospective, 16 week crossover study to determine the role of Pycnogenol in modifying blood pressure in mildly hypertensive patientsNutrition Research.(2001 September)
37.^Liu X, Wei J, Tan F, Zhou S, Würthwein G, Rohdewald PPycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patientsLife Sci.(2004 Jan 2)
38.^Zibadi S, Rohdewald PJ, Park D, Watson RRReduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementationNutr Res.(2008 May)
39.^Enseleit F, Sudano I, Périat D, Winnik S, Wolfrum M, Flammer AJ, Fröhlich GM, Kaiser P, Hirt A, Haile SR, Krasniqi N, Matter CM, Uhlenhut K, Högger P, Neidhart M, Lüscher TF, Ruschitzka F, Noll GEffects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over studyEur Heart J.(2012 Jul)
40.^Rezzani R, Porteri E, De Ciuceis C, Bonomini F, Rodella LF, Paiardi S, Boari GE, Platto C, Pilu A, Avanzi D, Rizzoni D, Agabiti Rosei EEffects of melatonin and Pycnogenol on small artery structure and function in spontaneously hypertensive ratsHypertension.(2010 Jun)
41.^van der Zwan LP, Scheffer PG, Teerlink TReduction of myeloperoxidase activity by melatonin and pycnogenol may contribute to their blood pressure lowering effectHypertension.(2010 Sep)
42.^Golański J1, Muchova J, Golański R, Durackova Z, Markuszewski L, Watała CDoes pycnogenol intensify the efficacy of acetylsalicylic acid in the inhibition of platelet function? In vitro experiencePostepy Hig Med Dosw (Online).(2006)
43.^Devaraj S, Vega-López S, Kaul N, Schönlau F, Rohdewald P, Jialal ISupplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profileLipids.(2002 Oct)
44.^Koch RComparative study of Venostasin and Pycnogenol in chronic venous insufficiencyPhytother Res.(2002 Mar)
45.^Nelson AB, Lau BH, Ide N, Rong YPycnogenol inhibits macrophage oxidative burst, lipoprotein oxidation, and hydroxyl radical-induced DNA damageDrug Dev Ind Pharm.(1998 Feb)
46.^Sensky T, Hughes T, Hirsch SCompulsory psychiatric treatment in the community. I. A controlled study of compulsory community treatment with extended leave under the Mental Health Act: special characteristics of patients treated and impact of treatmentBr J Psychiatry.(1991 Jun)
47.^Schmidt AJ, Krieg JC, Hemmeter UM, Kircher T, Schulz E, Clement HW, Heiser PImpact of plant extracts tested in attention-deficit/hyperactivity disorder treatment on cell survival and energy metabolism in human neuroblastoma SH-SY5Y cellsPhytother Res.(2010 Oct)
48.^Trebatická J, Kopasová S, Hradecná Z, Cinovský K, Skodácek I, Suba J, Muchová J, Zitnanová I, Waczulíková I, Rohdewald P, Duracková ZTreatment of ADHD with French maritime pine bark extract, PycnogenolEur Child Adolesc Psychiatry.(2006 Sep)
49.^Dvoráková M, Jezová D, Blazícek P, Trebatická J, Skodácek I, Suba J, Iveta W, Rohdewald P, Duracková ZUrinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): modulation by a polyphenolic extract from pine bark (pycnogenol)Nutr Neurosci.(2007 Jun-Aug)
50.^Luzzi R, Belcaro G, Zulli C, Cesarone MR, Cornelli U, Dugall M, Hosoi M, Feragalli BPycnogenol® supplementation improves cognitive function, attention and mental performance in studentsPanminerva Med.(2011 Sep)
51.^Tenenbaum S, Paull JC, Sparrow EP, Dodd DK, Green LAn experimental comparison of Pycnogenol and methylphenidate in adults with Attention-Deficit/Hyperactivity Disorder (ADHD)J Atten Disord.(2002 Sep)
52.^Errichi S, Bottari A, Belcaro G, Cesarone MR, Hosoi M, Cornelli U, Dugall M, Ledda A, Feragalli BSupplementation with Pycnogenol® improves signs and symptoms of menopausal transitionPanminerva Med.(2011 Sep)
53.^Inhibition of NF-κB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol).()
54.^Celec PNuclear factor kappa B--molecular biomedicine: the next generationBiomed Pharmacother.(2004 Jul-Aug)
55.^Lee YC, Lee HB, Rhee YK, Song CHThe involvement of matrix metalloproteinase-9 in airway inflammation of patients with acute asthmaClin Exp Allergy.(2001 Oct)
56.^Chung TW, Moon SK, Chang YC, Ko JH, Lee YC, Cho G, Kim SH, Kim JG, Kim CHNovel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanismFASEB J.(2004 Nov)
57.^Ho TY, Bagnell CARelaxin induces matrix metalloproteinase-9 through activation of nuclear factor kappa B in human THP-1 cellsAnn N Y Acad Sci.(2005 May)
58.^Lee KM, Kang BS, Lee HL, Son SJ, Hwang SH, Kim DS, Park JS, Cho HJSpinal NF-kB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivityEur J Neurosci.(2004 Jun)
59.^Schäfer A, Chovanová Z, Muchová J, Sumegová K, Liptáková A, Duracková Z, Högger PInhibition of COX-1 and COX-2 activity by plasma of human volunteers after ingestion of French maritime pine bark extract (Pycnogenol)Biomed Pharmacother.(2006 Jan)
61.^Luo H, Wang J, Qiao C, Ma N, Liu D, Zhang WPycnogenol attenuates atherosclerosis by regulating lipid metabolism through the TLR4-NF-κB pathwayExp Mol Med.(2015 Oct 23)
62.^Gu JQ, Ikuyama S, Wei P, Fan B, Oyama J, Inoguchi T, Nishimura JPycnogenol, an extract from French maritime pine, suppresses Toll-like receptor 4-mediated expression of adipose differentiation-related protein in macrophagesAm J Physiol Endocrinol Metab.(2008 Dec)
63.^Gao B, Chang C, Zhou J, Zhao T, Wang C, Li C, Gao GPycnogenol Protects Against Rotenone-Induced Neurotoxicity in PC12 Cells Through Regulating NF-κB-iNOS Signaling PathwayDNA Cell Biol.(2015 Oct)
64.^Liu R, Fan B, Cong H, Ikuyama S, Guan H, Gu JPycnogenol Reduces Toll-Like Receptor 4 Signaling Pathway-Mediated Atherosclerosis Formation in Apolipoprotein E-Deficient MiceJ Cardiovasc Pharmacol.(2016 Oct)
65.^Verlaet A, van der Bolt N, Meijer B, Breynaert A, Naessens T, Konstanti P, Smidt H, Hermans N, Savelkoul HFJ, Teodorowicz MToll-Like Receptor-Dependent Immunomodulatory Activity of Pycnogenol®Nutrients.(2019 Jan 22)
66.^Pycnogenol supplementation reduces pain and stiffness and improves physical function in adults with knee osteoarthritis.()
67.^Belcaro G, Cesarone MR, Errichi S, Zulli C, Errichi BM, Vinciguerra G, Ledda A, Di Renzo A, Stuard S, Dugall M, Pellegrini L, Errichi S, Gizzi G, Ippolito E, Ricci A, Cacchio M, Cipollone G, Ruffini I, Fano F, Hosoi M, Rohdewald PTreatment of osteoarthritis with Pycnogenol. The SVOS (San Valentino Osteo-arthrosis Study). Evaluation of signs, symptoms, physical performance and vascular aspectsPhytother Res.(2008 Apr)
68.^Wilson D, Evans M, Guthrie N, Sharma P, Baisley J, Schonlau F, Burki CA randomized, double-blind, placebo-controlled exploratory study to evaluate the potential of pycnogenol for improving allergic rhinitis symptomsPhytother Res.(2010 Aug)
69.^Choi YH, Yan GHPycnogenol inhibits immunoglobulin E-mediated allergic response in mast cellsPhytother Res.(2009 Dec)
70.^Khlevner J, Park Y, Margolis KGBrain-Gut Axis: Clinical ImplicationsGastroenterol Clin North Am.(2018 Dec)
72.^Adriani A, Ribaldone DG, Astegiano M, Durazzo M, Saracco GM, Pellicano RIrritable bowel syndrome: the clinical approachPanminerva Med.(2018 Sep 24)
73.^Belcaro G, Gizzi G, Pellegrini L, Feragalli B, Cotellese R, Cacchio M, Corsi MPycnogenol® supplementation improves the control of irritable bowel syndrome symptomsPanminerva Med.(2018 Jun)
74.^Rohdewald PA review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacologyInt J Clin Pharmacol Ther.(2002 Apr)
75.^Maia H Jr, Haddad C, Casoy JThe effect of pycnogenol on patients with dysmenorrhea using low-dose oral contraceptivesInt J Womens Health.(2014 Dec 11)
76.^Psianou K, Panagoulias I, Papanastasiou AD, de Lastic AL, Rodi M, Spantidea PI, Degn SE, Georgiou P, Mouzaki AClinical and immunological parameters of Sjögren's syndromeAutoimmun Rev.(2018 Oct)
77.^Luzzi R, Belcaro G, Hu S, Feragalli B, Hosoi M, Dugall M, Ledda AEfficacy of Pycnogenol® supplementation in remission phases of Sjögren syndromeMinerva Cardioangiol.(2018 Oct)
79.^Hu S, Belcaro G, Ledda A, Corsi M, Cotellese R, Feragalli B, Hosoi M, Dugall M, Torino-Rodriguez P, Cesarone MRBehçet syndrome: effects of Pycnogenol® supplementation during regression phasesMinerva Cardioangiol.(2018 Aug)
80.^Rohdewald PJReview on Sustained Relief of Osteoarthritis Symptoms with a Proprietary Extract from Pine Bark, PycnogenolJ Med Food.(2018 Jan)
81.^Belcaro G, Cesarone MR, Errichi S, Zulli C, Errichi BM, Vinciguerra G, Ledda A, Di Renzo A, Stuard S, Dugall M, Pellegrini L, Errichi S, Gizzi G, Ippolito E, Ricci A, Cacchio M, Cipollone G, Ruffini I, Fano F, Hosoi M, Rohdewald PTreatment of osteoarthritis with Pycnogenol. The SVOS (San Valentino Osteo-arthrosis Study). Evaluation of signs, symptoms, physical performance and vascular aspectsPhytother Res.(2008 Apr)
82.^Cisár P, Jány R, Waczulíková I, Sumegová K, Muchová J, Vojtassák J, Duraćková Z, Lisý M, Rohdewald PEffect of pine bark extract (Pycnogenol) on symptoms of knee osteoarthritisPhytother Res.(2008 Aug)
83.^Lee OH, Seo MJ, Choi HS, Lee BYPycnogenol® inhibits lipid accumulation in 3T3-L1 adipocytes with the modulation of reactive oxygen species (ROS) production associated with antioxidant enzyme responsesPhytother Res.(2012 Mar)
85.^Mochizuki M, Hasegawa NPycnogenol stimulates lipolysis in 3t3-L1 cells via stimulation of beta-receptor mediated activityPhytother Res.(2004 Dec)
86.^Changes in lipolysis and hormone-sensitive lipase expression caused by procyanidins in 3T3-L1 adipocytes.()
87.^Lee HH, Kim KJ, Lee OH, Lee BYEffect of pycnogenol on glucose transport in mature 3T3-L1 adipocytesPhytother Res.(2010 Aug)
88.^Preventive Effect of Pine Bark Extract (Flavangenol) on Metabolic Disease in Western Diet-Loaded Tsumura Suzuki Obese Diabetes Mice.()
89.^Packer L, Rimbach G, Virgili FAntioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenolFree Radic Biol Med.(1999 Sep)
90.^Noda Y, Anzai K, Mori A, Kohno M, Shinmei M, Packer LHydroxyl and superoxide anion radical scavenging activities of natural source antioxidants using the computerized JES-FR30 ESR spectrometer systemBiochem Mol Biol Int.(1997 Jun)
91.^Iravani S, Zolfaghari BPharmaceutical and nutraceutical effects of Pinus pinaster bark extractRes Pharm Sci.(2011 Jan)
92.^Sivonová M, Waczulíková I, Kilanczyk E, Hrnciarová M, Bryszewska M, Klajnert B, Duracková ZThe effect of Pycnogenol on the erythrocyte membrane fluidityGen Physiol Biophys.(2004 Mar)
93.^Voss P, Horakova L, Jakstadt M, Kiekebusch D, Grune TFerritin oxidation and proteasomal degradation: protection by antioxidantsFree Radic Res.(2006 Jul)
94.^Rong Y, Li L, Shah V, Lau BHPycnogenol protects vascular endothelial cells from t-butyl hydroperoxide induced oxidant injuryBiotechnol Ther.(1994-1995)
95.^Chida M, Suzuki K, Nakanishi-Ueda T, Ueda T, Yasuhara H, Koide R, Armstrong DIn vitro testing of antioxidants and biochemical end-points in bovine retinal tissueOphthalmic Res.(1999)
96.^Zižková P, Viskupičová J, Horáková LPycnogenol and Ginkgo biloba extract: effect on peroxynitrite-oxidized sarcoplasmic reticulum Ca-ATPaseInterdiscip Toxicol.(2010 Dec)
97.^Schäfer A, Högger POligomeric procyanidins of French maritime pine bark extract (Pycnogenol) effectively inhibit alpha-glucosidaseDiabetes Res Clin Pract.(2007 Jul)
98.^Liu X, Zhou HJ, Rohdewald PFrench maritime pine bark extract Pycnogenol dose-dependently lowers glucose in type 2 diabetic patientsDiabetes Care.(2004 Mar)
99.^Aoki H, Nagao J, Ueda T, Strong JM, Schonlau F, Yu-Jing S, Lu Y, Horie SClinical assessment of a supplement of Pycnogenol® and L-arginine in Japanese patients with mild to moderate erectile dysfunctionPhytother Res.(2012 Feb)
100.^Zibadi S1, Rohdewald PJ, Park D, Watson RRReduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementationNutr Res.(2008 May)
101.^Hosseini S, Pishnamazi S, Sadrzadeh SM, Farid F, Farid R, Watson RRPycnogenol((R)) in the Management of AsthmaJ Med Food.(2001 Winter)
102.^Belcaro G, Luzzi R, Cesinaro Di Rocco P, Cesarone MR, Dugall M, Feragalli B, Errichi BM, Ippolito E, Grossi MG, Hosoi M, Errichi S, Cornelli U, Ledda A, Gizzi GPycnogenol® improvements in asthma managementPanminerva Med.(2011 Sep)
103.^Mei L, Mochizuki M, Hasegawa NHepatoprotective Effects of Pycnogenol in a Rat Model of Non-alcoholic SteatohepatitisPhytother Res.(2012 Oct)
104.^Parveen K, Khan MR, Mujeeb M, Siddiqui WAProtective effects of Pycnogenol on hyperglycemia-induced oxidative damage in the liver of type 2 diabetic ratsChem Biol Interact.(2010 Jul 30)
105.^Ledda A, Belcaro G, Cesarone MR, Dugall M, Schönlau FInvestigation of a complex plant extract for mild to moderate erectile dysfunction in a randomized, double-blind, placebo-controlled, parallel-arm studyBJU Int.(2010 Oct)
106.^Stanislavov R, Nikolova VTreatment of erectile dysfunction with pycnogenol and L-arginineJ Sex Marital Ther.(2003 May-Jun)
107.^Stanislavov R, Nikolova V, Rohdewald PImprovement of erectile function with Prelox: a randomized, double-blind, placebo-controlled, crossover trialInt J Impot Res.(2008 Mar-Apr)
108.^Marini A, Grether-Beck S, Jaenicke T, Weber M, Burki C, Formann P, Brenden H, Schönlau F, Krutmann JPycnogenol® effects on skin elasticity and hydration coincide with increased gene expressions of collagen type I and hyaluronic acid synthase in womenSkin Pharmacol Physiol.(2012)
Primary Use
Secondary Use